Literature DB >> 21813739

Noninvasive assessment of transstenotic pressure gradients in porcine renal artery stenoses by using vastly undersampled phase-contrast MR angiography.

Thorsten A Bley1, Kevin M Johnson, Christopher J François, Scott B Reeder, Mark L Schiebler, Benjamin R Landgraf, Daniel Consigny, Thomas M Grist, Oliver Wieben.   

Abstract

PURPOSE: To compare noninvasive transstenotic pressure gradient (TSPG) measurements derived from high-spatial- and temporal-resolution four-dimensional magnetic resonance (MR) flow measurements with invasive measurements obtained from endovascular pressure wires with digital subtraction angiographic guidance.
MATERIALS AND METHODS: After Animal Care and Use Committee approval, bilateral renal artery stenosis (RAS) was created surgically in 12 swine. Respiratory-gated phase-contrast vastly undersampled isotropic projection (VIPR) MR angiography of the renal arteries was performed with a 1.5-T clinical MR system (repetition time, 11.4 msec; echo time [first echo], 3.7 msec; 18,000 projection angles; imaging volume, 260 × 260 × 200 mm; acquired isotropic spatial resolution, 1.0 × 1.0 × 1.0 mm; velocity encoding, 150 cm/sec). Velocities measured with phase-contrast VIPR were used to calculate TSPGs by using Navier-Stokes equations. These were compared with endovascular pressure measurements (mean and peak) performed by using fluoroscopic guidance with regression analysis.
RESULTS: In 19 renal arteries with an average stenosis of 62% (range, 0%-87%), there was excellent correlation between the noninvasive TSPG measurement with phase-contrast VIPR and invasive TSPG measurement for mean TSPG (R² = 95.4%) and strong correlation between noninvasive TSPG and invasive TSPG for the peak TSPG measures (R² = 82.6%). The phase-contrast VIPR-derived TSPG measures were slightly lower than the endovascular measurements. In four arteries with severe stenoses and one occlusion (mean, 86%; range, 75%-100%), the residual lumen within the stenosis was too small to determine TSPG with phase-contrast VIPR.
CONCLUSION: The unenhanced MR angiographic technique with phase-contrast VIPR allows for accurate noninvasive assessment of hemodynamic significance in a porcine model of RAS with highly accurate TSPG measurements. © RSNA, 2011.

Entities:  

Mesh:

Year:  2011        PMID: 21813739      PMCID: PMC3184231          DOI: 10.1148/radiol.11101175

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  27 in total

1.  Motion of the distal renal artery during three-dimensional contrast-enhanced breath-hold MRA.

Authors:  G Boudewijn C Vasbinder; Jeffrey H Maki; Robbert J Nijenhuis; Tim Leiner; Gregory J Wilson; Alfons G H Kessels; Etienne E L E Lemaire; Dave W Kaandorp; Kai Yiu J A M Ho; Jos M A van Engelshoven; Etienne E L E Lemarie
Journal:  J Magn Reson Imaging       Date:  2002-12       Impact factor: 4.813

2.  Guidelines for the reporting of renal artery revascularization in clinical trials.

Authors:  John H Rundback; David Sacks; K Craig Kent; Christopher Cooper; Daniel Jones; Timothy Murphy; Kenneth Rosenfield; Christopher White; Michael Bettmann; Stanley Cortell; Jules Puschett; Daniel G Clair; Patricia Cole
Journal:  J Vasc Interv Radiol       Date:  2002-10       Impact factor: 3.464

3.  Fast measurement of intracardiac pressure differences with 2D breath-hold phase-contrast MRI.

Authors:  Richard B Thompson; Elliot R McVeigh
Journal:  Magn Reson Med       Date:  2003-06       Impact factor: 4.668

4.  Utility of a 0.014" pressure-sensing guidewire to assess renal artery translesional systolic pressure gradients.

Authors:  William R Colyer; Christopher J Cooper; Mark W Burket; William J Thomas
Journal:  Catheter Cardiovasc Interv       Date:  2003-07       Impact factor: 2.692

5.  Time-resolved 3D MR angiography of the abdomen with a real-time system.

Authors:  Oliver Wieben; Thomas M Grist; Thomas F Hany; Frank J Thornton; John K Glaser; Dean H Skuldt; Walter F Block
Journal:  Magn Reson Med       Date:  2004-10       Impact factor: 4.668

6.  The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group.

Authors:  B C van Jaarsveld; P Krijnen; H Pieterman; F H Derkx; J Deinum; C T Postma; A Dees; A J Woittiez; A K Bartelink; A J Man in 't Veld; M A Schalekamp
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245

7.  [Studies on the differential determination of renin activity in renal venous blood in renal artery stenosis].

Authors:  T Huber; W Vetter; U Kuhlmann; H Vetter; G Pouliadis; W Meier; J Furrer; R Beckerhoff; U Vetter; W Siegenthaler
Journal:  Schweiz Med Wochenschr       Date:  1977-12-03

8.  Determination of renal arterial stenosis severity: comparison of pressure gradient and vessel diameter.

Authors:  C M Gross; J Krämer; O Weingärtner; F Uhlich; F C Luft; J Waigand; R Dietz
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

Review 9.  Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis.

Authors:  K T Tan; E J R van Beek; P W G Brown; O M van Delden; J Tijssen; L E Ramsay
Journal:  Clin Radiol       Date:  2002-07       Impact factor: 2.350

10.  Improved 3D phase contrast MRI with off-resonance corrected dual echo VIPR.

Authors:  Kevin M Johnson; Darren P Lum; Patrick A Turski; Walter F Block; Charles A Mistretta; Oliver Wieben
Journal:  Magn Reson Med       Date:  2008-12       Impact factor: 4.668

View more
  23 in total

Review 1.  Sub-Nyquist acquisition and constrained reconstruction in time resolved angiography.

Authors:  Charles A Mistretta
Journal:  Med Phys       Date:  2011-06       Impact factor: 4.071

2.  Pressure Mapping and Hemodynamic Assessment of Intracranial Dural Sinuses and Dural Arteriovenous Fistulas with 4D Flow MRI.

Authors:  L A Rivera-Rivera; K M Johnson; P A Turski; O Wieben
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-21       Impact factor: 3.825

3.  Regional hypoxic cerebral vasodilation facilitated by diameter changes primarily in anterior versus posterior circulation.

Authors:  J Mikhail Kellawan; John W Harrell; Alejandro Roldan-Alzate; Oliver Wieben; William G Schrage
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 4.  4D flow imaging: current status to future clinical applications.

Authors:  Michael Markl; Susanne Schnell; Alex J Barker
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

5.  Volumetric velocity measurements in restricted geometries using spiral sampling: a phantom study.

Authors:  Anders Nilsson; Johan Revstedt; Einar Heiberg; Freddy Ståhlberg; Karin Markenroth Bloch
Journal:  MAGMA       Date:  2014-05-18       Impact factor: 2.310

6.  Effect of TIPS placement on portal and splanchnic arterial blood flow in 4-dimensional flow MRI.

Authors:  Zoran Stankovic; Martin Rössle; Wulf Euringer; Michael Schultheiss; Riad Salem; Alex Barker; James Carr; Mathias Langer; Michael Markl; Jeremy D Collins
Journal:  Eur Radiol       Date:  2015-04-08       Impact factor: 5.315

Review 7.  Clinical Applications of MRA 4D-Flow.

Authors:  Lilia M Sierra-Galan; Christopher J François
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-09-10

8.  Inlet and outlet valve flow and regurgitant volume may be directly and reliably quantified with accelerated, volumetric phase-contrast MRI.

Authors:  Albert Hsiao; Umar Tariq; Marcus T Alley; Michael Lustig; Shreyas S Vasanawala
Journal:  J Magn Reson Imaging       Date:  2014-02-08       Impact factor: 4.813

9.  4D spiral imaging of flows in stenotic phantoms and subjects with aortic stenosis.

Authors:  M J Negahdar; Mo Kadbi; Michael Kendrick; Marcus F Stoddard; Amir A Amini
Journal:  Magn Reson Med       Date:  2015-04-27       Impact factor: 4.668

Review 10.  Emerging Applications of Abdominal 4D Flow MRI.

Authors:  Alejandro Roldán-Alzate; Christopher J Francois; Oliver Wieben; Scott B Reeder
Journal:  AJR Am J Roentgenol       Date:  2016-05-17       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.